Ocugen, Inc. (NASDAQ:OCGN) Q4 2019 Earnings Conference Call March 27, 2020 8:30 AM ET Company Participants Kelly Beck - Vice President, Investor Relations and Administration Shankar Musunuri - Chairman and Chief Executive Officer Sanjay Subramanian - Chief Financial Officer Dan Jorgensen - Chief Medical Officer Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Keay Nakae - Chardan Operator Good morning and welcome to the Ocugen Conference Call. At this time, all participants are in a l ...

Developing Transformative Therapies to Treat the Whole Eye NASDAQ: OCGN Corporate Deck Forward Looking Statement This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our business strategy, future results of operations and financial position, prospective products, product approvals, research and development costs, timing and likelihood of ...

Ocugen, Inc. (NASDAQ:OCGN) Q3 2019 Results Conference Call November 8, 2019 10:30 AM ET Company Participants Kelly Beck - Vice President, Investor Relations, Administration Shankar Musunuri - Chairman and Chief Executive Officer Sanjay Subramanian - Chief Financial Officer Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Operator Good morning, and welcome to Ocugen Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session for research analys ...